PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
16-May-2024 Pharmanovia and Closed Loop Medicine launch the OptiZest study to investigate personalised dose management in hypertension Pharmanovia
15-May-2024 Publication in Nature Immunology outlining the contribution of B cells to anticancer immunosurveillance highlights Alchemab’s capabilities and potential to develop new cancer therapies Alchemab
13-May-2024 Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification Sartorius
13-May-2024 Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck H. Lundbeck A/S
13-May-2024 Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration Macomics Ltd
13-May-2024 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6® ACCEPTED FOR USE IN SCOTLAND AS RELIEVER THERAPY FOR PATIENTS WITH MILD ASTHMA AGED 12 YEARS AND OLDER AstraZeneca
10-May-2024 New EU directive will require UK businesses trading with the EU to enforce ESG compliance within their supply chains INVERTO
10-May-2024 Bloomsbury Genetic Therapies showcases its First Preclinical Data on Parkinson’s Disease Program at the American Society of Gene & Cell Therapy 2024 Annual Meeting Bloomsbury Genetic Therapies Limited
09-May-2024 EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE WITH TECHNOLOGY TO ENHANCE DURABILITY Edwards Lifesciences
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell
09-May-2024 ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator ENA Respiratory
03-May-2024 Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation Lindus Health
03-May-2024 SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab SynOx Therapeutics Limited
03-May-2024 Kancera meets the primary objectives of the KAND145 clinical phase I study Kancera AB
02-May-2024 ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024 The European Laboratory Research & Innovation Group (ELRIG) UK
01-May-2024 CLERKENWELL HEALTH LAUNCHING FOUNDATION COURSE FOR PSYCHEDELIC-ASSISTED THERAPY Clerkenwell Health
30-Apr-2024 Bioscript Group acquires Enzyme Communications to bolster its medical writing, scientific content creation and storytelling capabilities Bioscript Group